Malik Kemal 4/A
4/A · ACCELERON PHARMA INC · Filed Feb 10, 2020
Insider Transaction Report
Form 4/AAmended
Malik Kemal
Director
Transactions
- Award
Option to Purchase Common Stock
2020-01-02+17,956→ 17,956 totalExercise: $52.61Exp: 2030-01-02→ Common Stock (17,956 underlying)
Footnotes (2)
- [F1]Due to a clerical error, the original Form 4 filed on January 3, 2020 listed the incorrect number of securities in columns 5, 7 and 9 of Table II.
- [F2]The shares of common stock underlying this stock option award vest in equal quarterly installments over the first three years after January 1, 2020.